Inicio › Cáncer de pulmón › Arizona

Ensayos clínicos de Cáncer de pulmón en Arizona

34 estudios sobre Cáncer de pulmón buscan participantes en Arizona.

Ciudades en Arizona

Texto oficial del estudio (inglés)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Mayo Clinic in Arizona - Phoenix, Phoenix
University of Arizona Cancer Center, Tucson

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

City of Hope - Phoenix, Goodyear

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Kingman Regional Medical Center, Kingman
Cancer Center at Saint Joseph's, Phoenix

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Cancer Center at Saint Joseph's, Phoenix

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

HonorHealth, Scottsdale

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Banner MD Anderson Cancer Center, Gilbert
Banner University Medical Center Phoenix, Phoenix
The University of Arizona Cancer Center - North Campus, Tucson

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Banner Health, Tucson

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06060613

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Mayo Clinic Scottsdale, Scottsdale

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Cancer Treatment Centers of America, Phoenix, Goodyear

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07154290

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Mayo Clinic Scottsdale, Scottsdale

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Banner MD Anderson Cancer Center, Gilbert

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

CTCA at Western Regional Medical Center, Goodyear

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT07288034

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Gilbert

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer

Mayo Clinic in Arizona, Scottsdale

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT06855524

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

ACRC Arizona Clinical Research Center, Tucson

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Banner Health- MD Anderson Cancer Center, Gilbert

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pioneer Research Center, Bullhead City
Ironwood Cancer & Research Centers, Chandler
Ironwood Cancer & Research Centers, Gilbert
y 6 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Palo Verde Hematology Oncology, Glendale

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A Registry for People With Lung Cancer

University of Arizona (Data Collection Only), Tucson

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06424327

Social Optimization Study

University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson

Reclutando

Edades de 18 a 99 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07564960

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Dr. Amit Kulkarni, Phoenix

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT04105270

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mayo Clinic Hospital in Arizona, Phoenix

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Kingman Regional Medical Center, Kingman
Cancer Center at Saint Joseph's, Phoenix
Mayo Clinic Hospital in Arizona, Phoenix
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Phoenix

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT05433142

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Banner Health MD Anderson, Gilbert

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 26 jun 2026 · NCT04614103

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Banner Health, Gilbert

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Kingman Regional Medical Center, Kingman

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

Arizona Oncology Associates, PC - NAHOA, Prescott Valley

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT05885698

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

University of Arizona Cancer Center, Tucson

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 abr 2026 · NCT07216209

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

HonorHealth Research Institute, Scottsdale
The University of Arizona Cancer Center, Tucson

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Scottsdale

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

HonorHealth Research Institute, Scottsdale

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 oct 2025 · NCT06228326

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Banner MD Anderson Cancer Center, Gilbert

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT06682793

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.